Suppr超能文献

美沙酮剂量、血浆水平及人体对海洛因的交叉耐受性。

Methadone dose, plasma level, and cross-tolerance to heroin in man.

作者信息

Volavka J, Verebey K, Resnick R, Mulé S

出版信息

J Nerv Ment Dis. 1978 Feb;166(2):104-9. doi: 10.1097/00005053-197802000-00004.

Abstract

The development of cross-tolerance between methadone and heroin was studied in postaddict volunteers who had been drug-free for at least 6 weeks. Two methadone dose schedules were used; each was employed in six subjects. One schedule brought the subjects to a dose of 40 mg, while the other brought them to 80 mg of methadone a day. Subjects received injections of heroin (0.214 mg/kg) and placebo at various times before and during methadone treatment. Pupillary and subjective effects of injections were measured. Plasma levels of methadone were determined concurrently. Subjects on both treatment schedules developed an incomplete cross-tolerance to this dose of heroin. As the dose and plasma level of methadone increased with time, the cross-tolerance to all heroin effects increased. Plasma levels did not affect the development of cross-tolerance independently of methadone dose. The most important contribution to the cross-tolerance to pupillary effects was made by the duration of methadone treatment. Furthermore, the cross-tolerance to the subjective effects of heroin developed earlier than that to the pupil effect.

摘要

在已戒毒至少6周的戒毒后志愿者中,研究了美沙酮和海洛因之间交叉耐受性的发展情况。使用了两种美沙酮剂量方案;每种方案在6名受试者中使用。一种方案使受试者的美沙酮剂量达到40毫克,而另一种方案使他们每天服用80毫克美沙酮。在美沙酮治疗前和治疗期间的不同时间,受试者接受海洛因(0.214毫克/千克)和安慰剂注射。测量注射的瞳孔和主观效应。同时测定美沙酮的血浆水平。两种治疗方案的受试者对该剂量的海洛因均产生了不完全交叉耐受性。随着美沙酮剂量和血浆水平随时间增加,对所有海洛因效应的交叉耐受性增加。血浆水平在不依赖美沙酮剂量的情况下不影响交叉耐受性的发展。美沙酮治疗的持续时间对瞳孔效应交叉耐受性的影响最为重要。此外,对海洛因主观效应的交叉耐受性比对瞳孔效应的交叉耐受性出现得更早。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验